Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
暂无分享,去创建一个
Maciej A Mazurowski | Jing Zhang | Lars J. Grimm | James I. Silber | Lars J Grimm | M. Mazurowski | Jing Zhang | Sora C Yoon | James I Silber
[1] F. B. Sørensen,et al. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[3] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[4] E Boven,et al. Breast cancer classification by proteomic technologies: current state of knowledge. , 2014, Cancer treatment reviews.
[5] D. D. Maki,et al. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape. , 2012, AJR. American journal of roentgenology.
[6] Daniel Birnbaum,et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. , 2005, Cancer research.
[7] M. Giger,et al. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. , 2010, Radiology.
[8] Jeffrey D Blume,et al. Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers. , 2013, AJR. American journal of roentgenology.
[9] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Dell’Era,et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.
[11] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[12] Oriol Casanovas,et al. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. , 2005, Cancer cell.
[13] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[14] G. Hortobagyi,et al. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Jiong Wu,et al. Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy. , 2010, Oncology reports.
[16] T. Karn,et al. The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial. , 2007, Breast.
[17] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[18] James C. Bezdek,et al. On cluster validity for the fuzzy c-means model , 1995, IEEE Trans. Fuzzy Syst..
[19] John David Fleig,et al. Assessment of Feasibility to Use Computer Aided Texture Analysis Based Tool for Parametric Images of Suspicious Lesions in DCE-MR Mammography , 2013, Comput. Math. Methods Medicine.
[20] C. Balleyguier,et al. Computed-aided diagnosis (CAD) in the detection of breast cancer. , 2013, European journal of radiology.
[21] S Michiels,et al. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Anne L. Martel,et al. Feature Selection in Computer-Aided Breast Cancer Diagnosis via Dynamic Contrast-Enhanced Magnetic Resonance Images , 2013, Journal of Digital Imaging.
[23] L. Carey,et al. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. , 2009, Seminars in radiation oncology.
[24] San-Gang Wu,et al. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy. , 2012, Breast.
[25] F. Vicini,et al. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy , 2007, Cancer.
[26] Ben Tran,et al. Luminal-B breast cancer and novel therapeutic targets , 2011, Breast Cancer Research.
[27] Mark Rosen,et al. A Multichannel Markov Random Field Framework for Tumor Segmentation With an Application to Classification of Gene Expression-Based Breast Cancer Recurrence Risk , 2013, IEEE Transactions on Medical Imaging.
[28] N. Hynes,et al. Potential for targeting the fibroblast growth factor receptors in breast cancer. , 2010, Cancer research.
[29] Y. Niu,et al. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments , 2011, Breast Cancer Research and Treatment.
[30] Anne L. Martel,et al. A margin sharpness measurement for the diagnosis of breast cancer from magnetic resonance imaging examinations. , 2011, Academic radiology.
[31] Li Lan,et al. Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers. , 2010, Academic radiology.
[32] Alan C. Evans,et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.
[33] E. Gallardo,et al. Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status. , 2007, Clinical breast cancer.
[34] Matthijs Oudkerk,et al. Computer-aided detection in breast MRI: a systematic review and meta-analysis , 2011, European Radiology.
[35] Barbara L. Smith,et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Monica Morrow,et al. Presenting Features of Breast Cancer Differ by Molecular Subtype , 2009, Annals of Surgical Oncology.
[37] P. Sánchez‐Rovira,et al. Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[38] John W M Martens,et al. Subtypes of breast cancer show preferential site of relapse. , 2008, Cancer research.
[39] C. Perou,et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.
[40] A Vignati,et al. Computer-aided diagnosis for dynamic contrast-enhanced breast MRI of mass-like lesions using a multiparametric model combining a selection of morphological, kinetic, and spatiotemporal features. , 2012, Medical physics.
[41] M. Giger,et al. Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. , 2004, Medical physics.